We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.54B
AUM Growth
+$120M
Cap. Flow
-$6.56M
Cap. Flow %
-0.43%
Top 10 Hldgs %
29.96%
Holding
232
New
47
Increased
111
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$31.9M
2
LW icon
Lamb Weston
LW
+$24.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.1M
4
GS icon
Goldman Sachs
GS
+$17.5M
5
FCNCA icon
First Citizens BancShares
FCNCA
+$16.3M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$31.8M
2
SNPS icon
Synopsys
SNPS
+$26.6M
3
KIM icon
Kimco Realty
KIM
+$23.1M
4
NI icon
NiSource
NI
+$21.1M
5
UNP icon
Union Pacific
UNP
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.76%
2 Technology 16.54%
3 Financials 14.35%
4 Industrials 13.12%
5 Consumer Staples 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
U icon
226
Unity
U
$13.8B
-27,054
Closed -$862K
UNP icon
227
Union Pacific
UNP
$174B
-91,303
Closed -$17.8M
XLRE icon
228
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.55B
-6,955
Closed -$250K
DM
229
DELISTED
Desktop Metal, Inc.
DM
-2,000
Closed -$52K
LTHM
230
DELISTED
Livent Corporation
LTHM
-74,539
Closed -$2.29M
AVEO
231
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-12,000
Closed -$99K
ATVI
232
DELISTED
Activision Blizzard
ATVI
-12,277
Closed -$913K

Similar funds

Cookson Peirce & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Cookson Peirce & Co held 232 positions worth $1.54B, up 8.4% from $1.42B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cookson Peirce & Co's Q4 2022 filing shows 47 new, 111 increased, 37 reduced and 30 closed positions. Its largest new stake was Lamb Weston: 283,180 shares worth $25.3M. The largest sale was AstraZeneca, an estimated $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Cookson Peirce & Co's largest Q4 2022 buy was Lamb Weston: 283,180 shares worth $25.3M.
  • Cookson Peirce & Co added most to Merck in Q4 2022, an estimated $31.9M increase.
  • Cookson Peirce & Co's biggest Q4 2022 reduction was AstraZeneca, cutting an estimated $31.8M.
  • Cookson Peirce & Co fully exited Synopsys in Q4 2022, selling an estimated $26.6M.
  • Cookson Peirce & Co's ten largest holdings make up 30% of its $1.54B portfolio in Q4 2022.
  • Cookson Peirce & Co opened 47 new positions and closed 30 in Q4 2022.
  • Cookson Peirce & Co's portfolio value rose 8.4% quarter-over-quarter to $1.54B.

Based on Cookson Peirce & Co's 13F filing for Q4 2022, filed 31 Jan 2023.